Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles

Showing results (361-370 of 501) with videos related to

Pageof 51
Sort By:
Epigenomics|November 8, 2012
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®))Simon J Harrison, Mark Bishton, Susan E Bates, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.
Haematologica|July 18, 2009
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series reportDavid Ritchie, Richard L Piekarz, Piers Blombery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockadeJayne S Sutherland, Lisa Spyroglou, Jennifer L Muirhead, et al.
Journal of Clinical Pathology|May 16, 2018
Novel genomic findings in multiple myeloma identified through routine diagnostic sequencingGeorgina L Ryland, Kate Jones, Melody Chin, et al.
Hematological Oncology|June 16, 2006
The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilizationColm Keane, Simon Gibbs, John F Seymour, et al.
The Journal of Physical Chemistry. A|August 4, 2012
Comparison of the accuracy of aerosol refractive index measurements from single particle and ensemble techniquesBernard J Mason, Simon-John King, Rachael E H Miles, et al.
British Journal of Haematology|August 4, 2004
Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cellsH Miles Prince, Paul J Simmons, Genevieve Whitty, et al.
British Journal of Haematology|November 28, 2008
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access programJoseph R Mikhael, Andrew R Belch, H Miles Prince, et al.
British Journal of Haematology|August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical featuresSaar Gill, Kirsten E Herbert, H Miles Prince, et al.
Pageof 51

Showing results (361-370 of 501) with videos related to

Sort By:
Pageof 51
Epigenomics|November 8, 2012
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®))Simon J Harrison, Mark Bishton, Susan E Bates, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.
Haematologica|July 18, 2009
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series reportDavid Ritchie, Richard L Piekarz, Piers Blombery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockadeJayne S Sutherland, Lisa Spyroglou, Jennifer L Muirhead, et al.
Journal of Clinical Pathology|May 16, 2018
Novel genomic findings in multiple myeloma identified through routine diagnostic sequencingGeorgina L Ryland, Kate Jones, Melody Chin, et al.
Hematological Oncology|June 16, 2006
The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilizationColm Keane, Simon Gibbs, John F Seymour, et al.
The Journal of Physical Chemistry. A|August 4, 2012
Comparison of the accuracy of aerosol refractive index measurements from single particle and ensemble techniquesBernard J Mason, Simon-John King, Rachael E H Miles, et al.
British Journal of Haematology|August 4, 2004
Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cellsH Miles Prince, Paul J Simmons, Genevieve Whitty, et al.
British Journal of Haematology|November 28, 2008
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access programJoseph R Mikhael, Andrew R Belch, H Miles Prince, et al.
British Journal of Haematology|August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical featuresSaar Gill, Kirsten E Herbert, H Miles Prince, et al.
Pageof 51